Cryo-Save Group N.V. - Buyback of shares
(Thomson Reuters ONE) -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international stem cell storage company and the largest family stem cell bank in
Europe, announces that it has commenced a new tranche of its share buyback
programme.
Based on the authorization granted by the General Meeting of Shareholders on 16
May 2012, Cryo-Save intends to buy approximately 120,000 shares representing
1.3% of its outstanding shares. This tranche of the share buyback programme will
have a maximum value of EUR 277,000 based on the stock price at 29 January
2013, and will be funded by the Group's existing cash reserves.
All shares acquired will be proposed for cancellation by the Board at the
upcoming Annual General Meeting on 15 May 2013.
The buyback programme will be executed by Kempen & Co.
Enquiries:
Arnoud van Tulder, Chief Executive Officer + 31 (0) 575 509 100
Please click here for full press release in PDF:
http://hugin.info/143308/R/1674284/545139.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1674284]
Unternehmensinformation / Kurzprofil:
Datum: 30.01.2013 - 16:29 Uhr
Sprache: Deutsch
News-ID 224612
Anzahl Zeichen: 1663
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 164 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group N.V. - Buyback of shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
